Statins are recommended for four main groups of people, based on guidelines from the American Heart Association and American College of Cardiology: those who already have cardiovascular disease, those with very high LDL cholesterol (190 mg/dL or above), adults aged 40 to 75 with diabetes, and adults aged 40 to 75 whose 10-year risk of a heart attack or stroke exceeds a certain threshold. Where you fall among these groups determines both whether you should take a statin and how aggressively it’s dosed.
If You Already Have Cardiovascular Disease
This is the clearest case for statin therapy. If you’ve had a heart attack, stroke, mini-stroke, unstable angina, a stent or bypass procedure, or peripheral artery disease, statins are recommended as part of what’s called secondary prevention. The goal is to stop a second event, and high-intensity statin therapy is the standard for patients 75 and younger. “High intensity” means a dose aimed at cutting your LDL cholesterol by at least 50%.
For people over 75 with established vascular disease, guidelines still support starting or continuing a statin. The evidence is solid enough that age alone isn’t a reason to stop treatment if you have a documented history of cardiovascular problems.
If Your LDL Is 190 mg/dL or Higher
When LDL cholesterol reaches 190 mg/dL or above, a high-intensity statin is recommended regardless of your calculated heart disease risk. No risk calculator is needed. This threshold applies to adults aged 20 to 75 and typically points to a genetic condition called familial hypercholesterolemia, where the body can’t clear LDL from the bloodstream efficiently. At these levels, the lifetime risk of cardiovascular damage is high enough that treatment is straightforward.
If You Have Diabetes
Diabetes significantly accelerates cardiovascular disease, which is why statins are recommended for nearly all adults with diabetes over age 40, even if they haven’t had a heart attack or stroke. The American Diabetes Association recommends statin therapy for any diabetic patient with overt cardiovascular disease, and for those over 40 who have at least one additional risk factor like high blood pressure, smoking, or abnormal cholesterol.
In practice, the criteria capture the vast majority of people with diabetes. For type 2 diabetes, the only group that might reasonably skip a statin is men under 32 or women under 38 who have a short disease duration (under 10 years), no cardiovascular disease, and no other risk factors. For type 1 diabetes, the cutoff is roughly age 30. Outside those narrow exceptions, statins are considered standard care.
Evidence also supports continuing statins in diabetic patients between 75 and 84 to prevent cardiovascular events and reduce mortality. The benefit in this age group holds up well.
If Your 10-Year Risk Score Is Elevated
For adults aged 40 to 75 who don’t have cardiovascular disease, diabetes, or extremely high LDL, the decision hinges on your estimated 10-year risk of a heart attack or stroke. This is calculated using the ASCVD Risk Estimator, which factors in your age, sex, race, blood pressure, cholesterol levels, smoking status, and whether you’re on blood pressure medication.
The U.S. Preventive Services Task Force sets two thresholds. If your 10-year risk is 10% or greater and you have at least one risk factor (high cholesterol, diabetes, high blood pressure, or smoking), starting a statin is a clear recommendation. If your risk falls between 7.5% and 10%, the recommendation is softer: a statin may be worth considering, but the benefit is smaller, and the decision should reflect your personal preferences.
Your doctor can run this calculation in a few minutes using a free online tool. It’s worth knowing your number, because many people with moderate risk don’t realize they’ve crossed the threshold.
Factors That Can Tip the Scale
If your 10-year risk lands in the borderline or intermediate range (roughly 5% to 20%), several additional factors can strengthen the case for starting a statin. The 2018 guidelines specifically highlight these “risk enhancers” because the standard calculator doesn’t account for everything.
- Family history of early heart disease: a first-degree male relative who had a heart attack or stroke before age 55, or a female relative before 65, independently raises your risk beyond what the calculator predicts.
- Chronic kidney disease: reduced kidney function is strongly linked to cardiovascular events. Patients with CKD (who aren’t on dialysis) benefit from statin therapy.
- Other conditions: metabolic syndrome, chronic inflammatory diseases like rheumatoid arthritis, South Asian ancestry, and elevated inflammatory markers can all push a borderline case toward treatment.
These factors exist because the standard risk calculator is imperfect. Two people with the same calculated risk can have very different actual risk profiles, and these enhancers help personalize the decision.
What About Adults Over 75?
This is the murkiest area. Both the AHA/ACC and the USPSTF acknowledge that evidence for starting statins in adults over 75 without existing cardiovascular disease or diabetes is thin. Neither organization makes a strong recommendation for primary prevention in this group.
The data suggest that statins reduce cardiovascular events and death in people aged 75 to 84 who have type 2 diabetes or known vascular disease. But for otherwise healthy adults over 75, and for anyone 85 or older without cardiovascular disease, the benefit appears minimal regardless of diabetes status. The UK’s NICE guidelines take a different approach, effectively recommending statins for everyone over 75 based on age-related risk alone, but US guidelines haven’t followed suit.
What Happens After You Start
Once you begin a statin, your first follow-up blood test is typically scheduled 4 to 12 weeks later. This checks whether the drug is lowering your LDL as expected and confirms you’re tolerating it. After that initial check, lipid panels are repeated every 3 to 12 months depending on your situation.
The most commonly reported side effect is muscle pain. In clinical practice, somewhere between 5% and 30% of statin users report muscle symptoms, but controlled studies consistently show that a large share of those complaints aren’t actually caused by the drug. In one well-designed crossover study where patients alternated between a statin and a placebo without knowing which was which, only about 36% of people with a history of muscle complaints experienced pain on the statin alone. Nearly 30% had pain on the placebo but not the statin. Another trial found similar patterns, with roughly 43% confirmed as true statin-related muscle symptoms. The takeaway: muscle aches are real for some people, but the nocebo effect, where expecting a side effect makes you feel it, plays a substantial role. If you experience muscle pain, a structured rechallenge with a different statin or a lower dose often resolves the issue.
How the Decision Gets Made
Outside the clear-cut categories (existing heart disease, very high LDL, diabetes with risk factors), statin decisions are meant to be a conversation. Your doctor calculates your risk, reviews any enhancing factors, and discusses the likely benefit against your preferences. For someone with a 10-year risk of 15% and a family history of early heart attacks, the case is strong. For someone at 8% with no enhancers, it’s more of a judgment call.
If you’re between 40 and 75, knowing your 10-year ASCVD risk score is the single most useful starting point. You can estimate it yourself using the ACC’s free online calculator with a recent cholesterol panel and blood pressure reading. That number, combined with the categories above, tells you where you stand.